Primary Site >> Stomach Cancer
Gene >> TAZ
|
|
|
|
|---|---|---|---|
|
Ref: Effects of the hippo signaling pathway in human gastric cancer. PMID: 24175801 |
Ref: MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. PMID: 25633292 Ref: PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. PMID: 26431277 |
Ref: Roles of RUNX in Hippo Pathway Signaling. PMID: 28299672 Ref: TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells. PMID: 28534974 |
Ref: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. PMID: 29402328 Ref: YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. PMID: 29669762 Ref: Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer. PMID: 30180862 |